Pediatric Solid Tumors Cancer Studies Currently Recruiting Participants at the University of Chicago Cancer Research Center

Study Number	Title
10985A	COG ANBL00B1: Neuroblastoma Biology Studies
15090A	COG D9902: A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
15145A	COG ANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch 14.18) In High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
15226B	COG AREN03B2: Renal Tumors Classification, Biology and Banking Study
15373A	COG AREN0532: Treatment for Very Low, Low and Standard Risk Favorable Histology Wilms Tumor
15375A	COG AREN0321: Treatment of High Risk Renal Tumors
15263A	NANT 9902, Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BSO) (NSC-326321) with Autologous Stem Cell Support for Pediatric Extracranial Solid Tumors (NCI 68).
15646A	COG ARAR0332: Treatment of Adrenocortical Tumors with Surgery plus Lymph Node Dissection and Multiagent Chemotherapy
16158A	COG AOST06B1, A COG protocol for collecting and banking osteosarcoma specimens
12-1169	A pharmacodynamic study of sirolimus in older children and adults with advanced solid malignancies

To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.